Medical devices, healthcare technology and the business of care
510(k) clearance · K252853

CAD - Lower GI (EC07-01)

Xiamen Inno Medical Technology Co., Ltd. · Decision date Aug 5, 2026

FDA DECISIONK252853

What did the FDA decide?

FDA records K252853 as a 510(k) premarket notification, with a decision dated Aug 5, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Aug 5, 2026

FDA source record

Regulatory record facts

Identifier
K252853
Regulatory pathway
510(k) premarket notification
Product code
QNP
Decision code
SESE
Decision date
Aug 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gastrointesinal Lesion Software Detection System.

Product code
QNP
FDA device class
2

FDA decision timeline

  1. K252853 received

    Application receipt date recorded by FDA.

  2. K252853 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QNP

Product / regulatory recordCompanyPathwayDecision dateSource
CADDIEK260133
Odin Medical Limited510(k) clearanceSep 12, 2026FDA
Fujifilm Corporation510(k) clearanceAug 7, 2026FDA
Cosmo Artificial Intelligence - Ai, Ltd.510(k) clearanceMay 29, 2026FDA
Magentiq Eye, Ltd.510(k) clearanceApr 3, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Xiamen Inno Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Xiamen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records